キャピラリー ゾーン電気泳動タンデム質量分析法による大規模なトップダウン プロテオミクス

Executive Industry Relevance

Large-scale top-down proteomics using CZE-ESI-MS/MS enables high-resolution characterization of proteoforms, supporting target validation and mechanistic de-risking in early discovery. The platform improves predictive confidence by resolving protein isoforms and post-translational modifications in complex proteomes, informing go/no-go decisions. Its scalability and reproducibility facilitate enterprise reuse across discovery biology and translational workflows.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of therapeutic hypotheses through high-resolution proteoform separation and identification.
• Operational Value: Supports biological de-risking by characterizing protein isoforms and modifications with high confidence.
• Strategic Value: Enhances predictive confidence for portfolio triage via sensitive detection of proteoform variants.

Screening & Assay Development

• Scientific Value: Prepares validated biological systems for downstream workflows through reproducible proteoform profiling.
• Operational Value: Enables assay standardization with quantitative outputs from high-sensitivity detection of intact proteins.
• Strategic Value: Improves screening readiness and platform reuse via scalable separation of complex proteomes.

Translational & Preclinical Research

• Scientific Value: Connects discovery to preclinical validation through disease-relevant proteoform characterization in complex samples.
• Operational Value: Ensures translational continuity by enabling consistent proteoform analysis across model systems.
• Strategic Value: Supports risk-adjusted advancement decisions via high-confidence identification of modification-driven proteoforms.

Pipeline & Workflow Integration

The method integrates into the discovery continuum from hypothesis testing through lead identification, enabling mechanistic de-risking and predictive analytics prior to preclinical commitment.

• Discovery Biology: Supports hypothesis testing and pathway clarification via high-resolution separation of proteoforms.
• Screening: Delivers assay readiness through reproducible, quantitative proteoform detection in complex mixtures.
• Analytics: Provides high-mass-resolution and high-scan-speed MS/MS data for confident proteoform identification and quantification.
• Translational Research: Enables preclinical continuity by characterizing proteoforms in disease-relevant systems like E.coli proteomes.
• Enterprise Reuse: Functions as a reusable platform for large-scale proteoform characterization across multiple projects and targets.

Operational & Enterprise Impact

• Scientific Value: Predictive confidence in target validation through high-resolution proteoform separation and sensitive detection.
• Operational Value: Standardization and reproducibility via automated CZE-MS/MS workflow with 90-minute separation window.
• Strategic Value: Better go/no-go decisions by reducing mechanistic ambiguity in protein function and modification landscapes.
• Portfolio Impact: Risk-adjusted prioritization enabled by confident identification of over 500 proteoforms and 190 proteins per run.

Implementation Considerations

• Requires expertise in capillary electrophoresis, mass spectrometry, and proteoform data analysis.
• Needs instrumentation including LPA-coated capillary, electrokinetically pumped sheath flow CE-MS interface, and ion trap mass spectrometer.
• Demands cross-team standardization for sample preparation, HF treatment safety, and data analysis using TopPIC.
• Involves adaptation considerations for varying sample loading volumes and complex proteome matrices.
• Includes practical limitations such as hazardous HF handling and requirement for high-purity reagents and solvents.

Biopharma FAQs